Kyongbo Pharmaceutical Co., Ltd (KOSE: A214390)
Health Care · Pharmaceuticals · KR
₩5,420.00
+0.56% today · -15.0% 1Y
Kyongbo Pharmaceutical Co., Ltd (KOSE: A214390) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $96.21M.
Over the last twelve months the share price has lost 15.0%, trading between 4.70K and 9.30K.
Tweenvest scores Kyongbo Pharmaceutical Co., Ltd across four factors: quality 57/100, value 57/100, growth 29/100. Its strongest factor is quality.
A214390 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $96.21M
- Revenue (TTM)
- $180.52M
- P/E
- 25.66
- EPS
- 211.21
- Dividend yield
- —
- Beta (5Y)
- 0.31
- 52-week high
- ₩9,300.00
- 52-week low
- ₩4,700.00
- Avg volume (3M)
- —
- Shares outstanding
- 23.91M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding CompanyASE: JPHM | $98.70M | JD1.54 | +3.36% |
| Pak Fah Yeow International LimitedSEHK: 239 | $97.30M | HK$2.45 | -0.41% |
| Grown Rogue International Inc.CNSX: GRIN | $96.43M | CA$0.55 | -9.84% |
| Renascience Inc.TSE: 4889 | $96.35M | ¥1,103.00 | -9.44% |
| PT Merck TbkIDX: MERK | $94.77M | Rp3,790.00 | +2.43% |
| KUKJEON Co.,LtdKOSDAQ: A307750 | $94.60M | ₩2,360.00 | +4.89% |
| AlzeCure Pharma AB (publ)OM: ALZCUR | $94.26M | Skr6.74 | -1.75% |
| Unité de Fabrication des Médicaments S.ABVMT: UMED | $94.01M | DT8.80 | +0.57% |
Figures last refreshed Oct 4, 2026.